Through the transaction, Lantheus has acquired OCTEVY™, a registrational-stage PET diagnostic imaging agent targeting neuroendocrine tumors, which complements Lantheus’ therapeutic candidate PNT2003, ...

BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Lantheus Holdings Inc. (LNTH) on Wednesday reported a loss of $11.8 million in its fourth quarter. On a per-share basis, the Bedford, Massachusetts ...

Explore Lantheus Holdings stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LNTH. Root And ZoomInfo Are Among Top 8 Mid-Cap Gainers Last Week (Feb 24-Feb ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. After ...

BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to ...